NATCO Pharma Limited

₹805.05As of Sun 8 Nov 2026, 12:00 UTC
NSE:NATCOPHARMHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 3.99%
Div yield 0.62%
ROE 16.85%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.18
PE TTM 12.60
TSR TTM (0.49%)
Mkt cap ₹157.9B
ROIC 10.16%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹951
18.15%
(60.27%)
Hold 6|0|12|7|8
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
14.62
14.11
13.67
13.92
7.27%
4.37%
(7.14%)
(5.40%)
Revenue₹B
7.380
7.622
7.986
8.118
7.70%
10.61%
9.43%
10.90%
Peers (US$1.686B)
Cap (US$)
PE
1.713B
90.31x
1.576B
42.18x
Capital
TTM
5Y
10Y
Leveragex
0.662
0.367
0.357
EBIT/Intx
0.381
0.086
0.084
Own earn%
54.01
(16.62)
(28.06)
Sh yield%
42.05
32.43
32.04
Owners
Insiders/Inst%
11.60
89.67
Short interest%
1.29
SBC / revenue%
2.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
27–31
$1 testx
0.1
Incr. ROIC%
2